Clinical Trial Update: Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on a comparative efficacy and safety study in active ulcerative colitis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Tillotts Pharma AG | Conditions: Active Ulcerative Colitis | Phase 3 | Status: COMPLETED